Kaleorid

Potassium Chloride, the active ingredient in Kaleorid, is an electrolyte presented as an oral formulation for oral use. It is employed to correct low potassium levels and support electrolyte balance in patients with hypokalemia or potassium deficiency. Kaleorid provides a reliable source of potassium ions to help maintain normal cellular function and cardiac rhythm.

GNH USA supplies Kaleorid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, continually ensuring quality assurance and regulatory compliance across global markets.

Kaleorid (potassium chloride) is used to address electrolyte disturbances, particularly low potassium levels, by replenishing potassium in the body.

- Hypokalemia: restores normal serum potassium concentrations in patients with clinically significant potassium depletion. - Potassium deficiency: supplies essential potassium to prevent or treat deficiency states caused by inadequate intake or excessive loss. - Diuretic‑induced potassium loss: counteracts potassium depletion associated with the use of loop or thiazide diuretics.

Potassium chloride may cause a range of adverse reactions, varying from mild gastrointestinal discomfort to serious electrolyte disturbances.

Common Side Effects: - Nausea: mild stomach upset after oral intake. - Abdominal discomfort: cramping or pain in the stomach area. - Diarrhea: loose stools following dosing.

Serious or Rare Side Effects: - Hyperkalemia: dangerously high serum potassium that can affect heart rhythm. - Cardiac arrhythmia: irregular heartbeat that may cause palpitations or syncope. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis.

When prescribing or using Kaleorid, several precautions should be observed to ensure safe and effective therapy.

- Baseline assessment: check serum potassium and renal function before initiating therapy. - Monitoring: regularly monitor potassium levels during treatment to avoid overcorrection. - Dose adjustment: modify dose in patients with impaired renal function or those on potassium‑sparing agents. - Drug interactions: be cautious when co‑administered with ACE inhibitors, ARBs, or potassium‑sparing diuretics. - Contraindication: avoid use in patients with existing hyperkalemia or severe renal failure. - Store at ambient temperature: keep the product in its original packaging, protect from moisture and direct sunlight.

Potassium chloride can interact with several medications, influencing potassium balance or cardiac function.

Major Interactions (Avoid): - ACE inhibitors: may increase serum potassium leading to hyperkalemia. - Angiotensin receptor blockers (ARBs): similar risk of elevated potassium. - Potassium‑sparing diuretics (e.g., spironolactone): can cause additive potassium increase. - Trimethoprim‑sulfamethoxazole: may raise potassium levels. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can reduce renal potassium excretion.

Moderate Interactions (Monitor Closely): - Digoxin: high potassium may reduce digoxin toxicity but requires monitoring. - Beta‑blockers: may enhance bradycardic effects in hyperkalemia. - Lithium: altered renal handling may affect lithium levels.